Frisch Medical Device Private Limited
Clinical trials sponsored by Frisch Medical Device Private Limited, explained in plain language.
-
New heart stent shows promise in 888-Patient trial
Disease control CompletedThis study tested a new drug-coated stent called EvroSure in 888 people with blocked heart arteries. The stent releases medicine to keep the artery open and prevent future blockages. Researchers tracked major heart events like heart attacks or the need for repeat procedures at 30…
Phase: PHASE4 • Sponsor: Frisch Medical Device Private Limited • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New balloon treatment for clogged arteries shows promise
Disease control CompletedThis study tested a special balloon coated with sirolimus, a drug that helps keep heart arteries open after a blockage is cleared. 360 adults with coronary artery disease were treated and followed for 12 months to see if the balloon reduced major heart problems like heart attack …
Phase: PHASE4 • Sponsor: Frisch Medical Device Private Limited • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC